|
|
European Markets for Obesity Surgery DevicesPublished by: Frost & Sullivan Published: Jun. 22, 2005 Table of Contents1. Executive Summary 1. Executive Summary 1. Summary of the Market for Obesity Surgery Devices 2. Glossary of Terms 1. Glossary of Terms 1. Procedures and Abbreviations 3. Introduction and Background 1. An Overview of Obesity 1. Obesity as a Disease 2. Obesity in Europe 4. European Market for Obesity Surgery Devices - Market Dynamics 1. Market Overview 1. Introduction to Obesity Surgery Devices 2. Industry Challenges and Issues 1. Industry Challenges 3. Market Drivers and Restraints 1. Market Drivers a. Increase in the Obese Population b. Increase in Awareness of Obesity as a Dangerous Disease c. Expected Reimbursement by National Health Authorities d. Liklihood of Obese Children to Grow into Obese Adults e. Interest by Venture Capitalist Firms 2. Market Restraints a. Inadequate Reimbursement and Funding b. Lack of Awareness of the Extent and Scope of the Problem c. Significant Lifestyle Changes Required Post-Operation d. Preference for Non-Surgical Alternatives 5. Market Engineering Research for the Total European Market for Obesity Surgery Devices 1. Market Measurements and Forecasts 1. Market Engineering Research Measurements 2. Revenue Forecast 3. Market Share Analysis 4. Competitive Structure 6. Segment Analysis and Forecasts of the European Market for Obesity Surgery Devices 1. Segment Analysis and Forecasts 1. Segment Analysis 2. Adjustable Gastric Banding Devices: Revenue Forecast 3. Gastric Bypass Devices: Revenue Forecast 4. Vertical Banded Gastroplasty Devices: Revenue Forecast 5. Gastric Stimulator and Intragastric Balloon Devices: Revenue Forecast 6. Emerging Technologies 7. Geographic Analysis for the European Market for Obesity Surgery Devices 1. The Obesity Surgery Devices Market in Germany 1. Country Overview 2. Market Analysis 2. The Obesity Surgery Devices Market in France 1. Country Overview 2. Market Analysis 3. The Obesity Surgery Devices Market in the United Kingdom 1. Market Overview 2. Market Analysis 4. The Obesity Surgery Devices Market in Italy 1. Market Overview 2. Market Analysis 5. The Obesity Surgery Devices Market in Spain 1. Market Overview 2. Market Analysis 6. The Obesity Surgery Devices Market in Benelux 1. Market Overview 2. Market Analysis 7. The Obesity Surgery Devices Market in Scandinavia 1. Market Overview 2. Market Analysis 8. End-user Perceptions 1. Obesity Surgery: The Surgeons Perspective 1. Choice of Surgical Alternative 2. Challenges Perceived 9. Market Engineering Strategy 1. Strategic Recommendations for the European Obesity Surgery Devices Market 1. Strategic Recommendations 10. Database of Key Industry Participants 1. Database of Key Industry Participants 1. Key Industry Participants 11. Frost & Sullivan Awards for the European Market for Obesity Surgery Devices 1. Awards for the European Obesity Surgery Devices Market 1. Frost & Sullivan Awards 2. Market Penetration Leadership Award 3. Product Differentiation Innovation Award 4. Entrepreneurial Company Award 12. Decision Support Databases 1. Decision Support Databases on Demographics 1. Total Population in Europe 2. Adult Obese Population in Europe 3. Per Cent of Diabetes Prevalence in Europe 2. Decision Support Databases on Healthcare Expenditure 1. Total Healthcare Expenditure in Europe 2. Private Healthcare Expenditure in Europe 3. Government Healthcare Expenditure in Europe 4. Per Capita Healthcare Expenditure in Europe AbstractRising Concern Regarding Obesity as a Major Disease Drives Market Growth The World Health Organisation’s (WHO) report on obesity concludes that there has been an increase in the occurrence of this condition by about 10-40 per cent in most of the European countries over the past decade. With obesity reaching epidemic proportion, there is tremendous scope for the development of new technologies and solutions that can help counter its impact. Although obesity surgeries have gained many takers over the past few years, the changing healthcare structures and reimbursement infrastructure across Europe have limited their widespread popularity. As the European Union and the different national healthcare organisations start recognising the increasing proportion of obese population and the danger of co-morbidities (associated disease such as hypertension, type II diabetes and cardiovascular diseases, among others), new obesity management initiatives are expected to bolster further acceptance of these surgeries. This Frost & Sullivan research service analyses the European markets for obesity surgery devices, segmenting them into adjustable gastric banding gastric bypass, vertical banded gastroplasty, gastric stimulator and intragastric balloon devices. It also discusses the various market trends and opportunities while providing in-depth analysis of market share, forecasts, drivers, restraints and revenues. The comprehensive focus of this study will enable companies to align their positioning strategies to benefit from the changing markets and obtain maximum return on investment. Obesity Surgery Devices Proving to be a Growing Market In 2004, adjustable gastric banding (AGB) emerged as the most popular procedure in Europe, registering the highest revenue growth among the segments of the European obesity surgery devices market and was followed by gastric bypass (GB). Being a more drastic and malabsorptive procedure that requires more recovery time compared to AGB, the European market for GB is still in a growing stage. However, GB has proven to be marginally more effective during long-term treatment of morbid obesity and combating co-morbidities such as type II diabetes. Participants can drive future growth by providing customers with long-term solutions and specialised medical support after obesity surgeries. "Surgeon training has become vital to increase the efficiency of obesity surgeries," says the analyst of this research. "The ability to provide follow-ups and to recommend support for post-operative maintenance has become a significant challenge in the provision of these surgeries." Increasing Interest Shown by Venture Capitalist Firms In recent years, venture capitalists have increased their funding for a number of start-ups catering to the moderately obese population, where the risk of surgery is lower and where technological solutions such as the gastric stimulator and intragastic balloon devices can result in moderate weight loss. "Interest by venture capitalists means greater technological advances, more competition in the provision of solutions and, eventually, an expansion of the market in terms of its scope and application," says the analyst. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||